Riik: Jordaania
keel: inglise
Allikas: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)
Ciclosporin 100 mg/ml
شركة مستودع الأدوية الأردني - The Jordan Drugstore Co
L04AA01
Ciclosporin 100 mg/ml
100 mg/ml
50ml
Delpharm Huningue S.A.S (فرنسا)
132.59 :سعر الجمهور + الضريبة
SANDIMMUN NEORAL ® COMPOSITION _Active substance: _Ciclosporin. _Excipients: _ Soft-gelatin capsules Capsule content: alpha–tocopherol, ethanol anhydrous, propylene glycol, corn oil–mono–di– triglycerides, macrogolglycerol hydroxystearate (Ph.Eur)/ polyoxyl 40 hydrogenated castor oil (NF). Sandimmun Neoral soft gelatin capsules contain 11.8% v/v ethanol (9.4% w/v). Capsule shell: Iron oxide black (E 172) (25- and 100-mg capsules), titanium dioxide (E 171), glycerol 85%, propylene glycol, gelatin. Imprint: carminic acid (E 120). Oral solution alpha–tocopherol, ethanol anhydrous, propylene glycol, corn oil-mono–di–triglycerides, macrogolglycerol hydroxystearate (Ph.Eur)/polyoxyl 40 hydrogenated castor oil (USP).Sandimmun Neoral oral solution contains 12% v/v ethanol (9.5% w/v). Information might differ in some countries. PHARMACEUTICAL FORM AND QUANTITY OF ACTIVE SUBSTANCE PER UNIT _Capsules_ containing 10, 25, 50 or 100 mg. _Oral solution_ containing 100 mg/ml. _Sandimmun_ is also available as a concentrate for i.v. infusion. See corresponding prescribing information. INDICATIONS/POTENTIAL USES _Transplantation_ _Organ transplantation_ Prevention of rejection of kidney, liver, heart, combined heart-lung, lung and pancreas allografts. Treatment of transplant rejection in patients previously treated with other immunosuppressive agents. _Bone marrow transplantation_ Prevention of graft rejection following bone marrow transplantation. Prevention and treatment of graft-versus-host disease (GVHD). _Non-transplantation indications_ _Endogenous uveitis_ Active sight-threatening intermediate or posterior uveitis of non-infectious aetiology in which alternative therapy has proved ineffective or inappropriate. Uveitis in Behçet’s disease, with recurrent inflammatory attacks involving the retina, in patients with normal renal function who are 7 to 70 years of age. _Psoriasis_ Treatment of severe cases of psoriasis in which alternative therapies are ineffective or inappropriate. _Atopic dermatitis_ Treatment Lugege kogu dokumenti